« Another Vote Against Rhodanines |
Main
| How Come? »
May 23, 2012
Drug Discovery on Radio 4
Posted by Derek
Several readers sent along a link to this Radio 4 program ("The End of Drug Disocvery") from the BBC on drug discovery. From what I've heard, it's a very good overview of the current state of the field for people outside it, and gets across just how difficult it's been to find good drug candidates.
Comments (4)
+ TrackBacks (0) | Category: Press Coverage
POST A COMMENT
- RELATED ENTRIES
- › AstraZeneca's Move To Hot, Happening Cambridge
- › Stealing A Compound, To Set Up in China
- › Tecfidera's Price
- › Novartis Loses the Glivec Patent Fight in India
- › ChemBark Closing Down (Update: Not Really!)
- › Fake Journals - But They'd Like Real Money
- › Chemical Probes Versus Drugs
- › Two New Books
1. petros on May 23, 2012 10:09 AM writes...
Had missed this so thanks for the plug Derek.
An interesting set of interviewees including
Chas Bountra (Structural Genomics Consortium)
Patrick Vallance (GSK)
Paul Workman
Also had a non-pharma academic claiming that the use of stem cells will deliver human tissue for all sorts of tox studies!
Permalink to Comment2. Anonymous on May 23, 2012 10:16 AM writes...
Nice overview, even if a bit basic for the readership here. Great to hear Patrick Vallance speak so eloquently and with such evident erudition. Patrick has been very supportive of pre-competitive alliances, just check out the game-changing Pistoia Alliance for a working example of this where GSK is one of the main drivers!
Permalink to Comment3. DrSnowboard on May 23, 2012 5:00 PM writes...
@2 Nice summary, even if a bit obvious and toadying for the readership here. Great to hear your unbiased and gushing praise of 'Patrick', we all call him by his first name here, just check out my previous game-changing press releases..err I mean posts on the GSK internal blogs!
Permalink to Comment4. johnnyboy on May 23, 2012 8:03 PM writes...
@3: you have stumbled upon The Commenter Formerly Known as Agilist, and lord knows how many other pseudonyms. He pops up here every single time something about GSK is mentioned, to toot the company's horn. Obviously the GSK cuts haven't fully affected the PR department yet.
Permalink to Comment